Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes

Nucleic Acids Research

Volumn 37, Issue 12, 2009, Pages 3850-3864

  Kippenberger, Stefan ^a   Müller, Jutta ^a   Schultz, Maike ^a   Dorn, Annette ^a   Bock, Andreas ^b   Aygün, Hüseyin ^c   Thaçi, Diamant ^a   Hofmann, Matthias ^a   Kaufmann, Roland ^a   Bernd, August ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HENKEL KGAA   (Germany)

^c BioSpring GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CPG OLIGODEOXYNUCLEOTIDE; CYTOCHROME C; CYTOSOLIC CYTOCHROME C; DNA; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE ASSOCIATED DNA FRAGMENT; NONCPG CONTAINING OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE; PROTEIN KINASE B; STAUROSPORINE; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME REPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; SKIN EPITHELIUM;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA; HUMANS; KERATINOCYTES; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TOLL-LIKE RECEPTOR 9;

EID: 67651159061     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp252     Document Type: Article

References (43)

1. Coley,W.B. (1893) The treatment of malignant tumors by repeated inoculations with of erysipelas with a report of ten original cases. Am. J. Med. Sci., 105, 487-511.
2. Coley,W.B. (1884) Treatment of inoperable malignant tumors with the toxins of erysipelas and the bacillus prodigiosus. Am. J. Med. Sci. 108, 183-212.
3. Tokunaga,T., Yamamoto,H., Shimada,S., Abe,H., Fukuda,T., Fujisawa,Y., Furutani,Y., Yano,O., Kataoka,T. and Sudo,T. (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization and antitumor activity. J. Natl Cancer Inst., 72, 955-962.
4. Krieg,A.M., Yi,A.-K, Matson,S., Waldschmidt,T.J., Bishop,G.A., Teasdale,R., Koretzky,G.A. and Klinman,D.M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
5. Bird,A.P. (1985) CpG islands and genes. Curr. Opin. Genet., 5 309-314.
6. Bird,A.P. (1987) CpG islands as gene markers in the vertebrate nucleus. Trends Genet., 3, 342-347.
7. Hergersberg,M. (1991) Biological aspects of cytosine methylation in eukaryotic cells. Experientia, 47, 1171-1185.
8. Hemmi,H., Takeuchi,O., Kawai,T., Kaisho,T., Sato,S., Sanjo,H., Matsumoto,M., Hoshino,K., Wagner,H., Takeda,K. and Akira,S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature, 408, 740-745.
9. Dorn,A. and Kippenberger,S. (2008) Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators. Curr. Opin. Mol. Ther., 10, 10-20.
10. Stein,C.A., Subasinghe,C., Shinozuka,K. and Cohen,J.S. (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res., 16, 3209-3221.
11. Matteucci,M. (1997) Oligonucleotide analogues: An overview. Ciba Found Symp., 209, 5-14.
12. Tokunaga,T., Yano,O., Kuramoto,E., Kimura,Y., Yamamoto,T., Kataoka,T. and Yamamoto,S. (1992) Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol., 36, 55-66.
13. Yamamoto,T., Yamamoto,S., Kataoka,T. and Tokunaga,T. (1994) Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol. Immunol., 38, 831-836.
14. Liang,H., Nishioka,Y., Reich,C.F., Pisetsky,D.S. and Lipsky,P.E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest., 98, 1119-1129.
15. Dorn,A., Ludwig,R.J., Bock,A., Thaci,D., Hardt,K., Bereiter-Hahn,J., Kaufmann,R., Bernd,A. and Kippenberger,S. (2007) Oligonucleotides suppress IL-8 in skin keratinocytes in vitro and o.er anti-in.ammatory properties in vivo. J. Invest. Dermatol, 127, 846-854.
16. Luo,H.R. and Loison,F. (2008) Constitutive neutrophil apoptosis: Mechanisms and regulation. Am. J. Hematol., 83, 288-295.
17. Bauer,S., Kirschning,C.J., Hacker,H., Redecke,V., Hausmann,S., Akira,S., Wagner,H. and Lipford,G.B. (2001) Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA, 98, 9237-9242.
18. Kippenberger,S., Bernd,A., Loitsch,S., Guschel,M., Muller,J., Bereiter-Hahn,J. and Kaufmann,R. (2000) Signaling of mechanical stretch in human keratinocytes via MAP kinases. J. Invest. Dermatol., 114, 408-412.
19. Karasek,M.A. (1980) Effect of chemical modification of keratinocytes and collagen in keratinocyte-collagen interaction. Curr. Probl. Dermatol. 10, 143-158.
20. Leist,M., Single,B., Naumann,H., Fava,E., Simon,B., Kuhnle,S. and Nicotera,P. (1999) Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun., 258, 215-221.
21. Kuo,C.C., Liang,C.M., Lai,C.Y. and Liang,S.M. (2007) Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide. J. Immunol., 178, 6100-6108.
22. Medzhitov,R., Preston-Hurlburt,P., Kopp,E., Stadlen,A., Chen,C., Ghosh,S. and Janeway,C.A. Jr (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell, 2, 253-258.
23. Kippenberger,S., Loitsch,S., Guschel,M., Muller,J., Knies,Y., Kaufmann,R. and Bernd,A. (2005) Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor. J. Biol. Chem., 280, 3060-3067.
24. Jozsef,L., Khreiss,T. and Filep,J.G. (2004) CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J., 18, 1776-1778.
25. Vollmer,J., Janosch,A., Laucht,M., Ballas,Z.K., Schetter,C. and Krieg,A.M. (2002) Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. Antisense Nucleic Acid Drug Dev., 12, 165-175.
26. Sano,K., Shirota,H., Terui,T., Hattori,T. and Tamura,G. (2003) Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner. J. Immunol., 170, 2367-2373.
27. Vollmer,J., Weeratna,R.D., Jurk,M., Samulowitz,U., McCluskie,M.J., Payette,P., Davis,H.L., Schetter,C. and Krieg,A.M. (2004) Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology, 113, 212-223.
28. Takeshita,F., Leifer,C.A., Gursel,I., Ishii,K.J., Takeshita,S., Gursel,M. and Klinman,D.M. (2001) Cutting edge. Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558.
29. Chuang,T.H., Lee,J., Kline,L., Mathison,J.C. and Ulevitch,R.J. (2002) Tolllike receptor 9 mediates CpG-DNA signaling. J. Leukoc. Biol., 71, 538-544.
30. Franke,T.F., Kaplan,D.R., Cantley,L.C. and Toker,A. (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science, 275, 665-668.
31. Kennedy,S.G., Wagner,A.J., Conzen,S.D., Jordan,J., Bellacosa,A., Tsichlis,P.N. and Hay,N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713.
32. Alessi,D.R., Deak,M., Casamayor,A., Caudwell,F.B., Morrice,N., Norman,D.G., Gaffney,P., Reese,C.B., MacDougall,C.N., Harbison,D. et al. (1997) 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol., 7, 776-789.
33. Toker,A. and Newton,A.C. (2000) Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275, 8271-8274.
34. Attwell,S., Roskelley,C. and Dedhar,S. (2000) The integrin-linked kinase (ILK) suppresses anoikis. Oncogene, 19, 3811-3815.
35. Alessi,D.R., Andjelkovic,M., Caudwell,B., Cron,P., Morrice,N., Cohen,P. and Hemmings,B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15, 6541-6551.
36. Kandel,E.S. and Hay,N. (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res., 253, 210-229.
37. Khwaja,A. (1999) Akt is more than just a Bad kinase. Nature, 401, 33-34.
38. Rusinol,A.E., Thewke,D., Liu,J., Freeman,N., Panini,S.R. and Sinensky,M.S. (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J. Biol. Chem., 279 1392-1399.
39. Slee,E.A., Harte,M.T., Kluck,R.M., Wolf,B.B., Casiano,C.A., Newmeyer,D.D., Wang,H.G., Reed,J.C., Nicholson,D.W., Alnemri,E.S. et al. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol., 144, 281-292.
40. Burgering,B.M. and Coffer,P.J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 376, 599-602.
41. Franke,T.F., Yang,S.I., Chan,T.O., Datta,K., Kazlauskas,A., Morrison,D.K., Kaplan,D.R. and Tsichlis,P.N. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81, 727-736.
42. Kohn,A.D., Kovacina,K.S. and Roth,R.A. (1995) Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/ thr kinase. EMBO J., 14, 4288-4295.
43. Rockwell,P., O'Connor,W.J., King,K., Goldstein,N.I., Zhang,L.M. and Stein,C.A. (1997) Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc. Natl Acad. Sci. USA, 94, 6523-6528.